Agios Pharmaceuticals earnings were -$411.3M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest AGIO earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$100.7M, up 1.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, AGIO reported annual earnings of -$412.8M, with -161.3% growth. The next AGIO earnings date is Oct 29, 2026.
Agios Pharmaceuticals Earnings Reports & History FAQ
What were Agios Pharmaceuticals's earnings last quarter?
On AGIO's earnings call on Jul 30, 2026, Agios Pharmaceuticals (NASDAQ: AGIO) reported Q2 2026 earnings per share (EPS) of -$1.69, up 12.44% year over year. Total AGIO earnings for the quarter were -$100.70 million. In the same quarter last year, Agios Pharmaceuticals's earnings per share (EPS) was -$1.93.
The next AGIO earnings call is Oct 29, 2026. Add AGIO to your watchlist to be reminded of Agios Pharmaceuticals's next earnings date.
Is Agios Pharmaceuticals profitable or losing money?
As of the last Agios Pharmaceuticals earnings report, Agios Pharmaceuticals is currently losing money. Agios Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$411.29 million, a 163.27% decrease year over year.
What was AGIO's earnings growth in the past year?
As of Agios Pharmaceuticals's earnings date in Jul 30, 2026, Agios Pharmaceuticals's earnings has grown year over year. AGIO earnings in the past year totalled -$411.29 million.
What are Agios Pharmaceuticals's earnings expectations?
The current EPS estimate for Agios Pharmaceuticals's earnings report in Oct 29, 2026 is -$1.32.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.